Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence
Authors
Keywords
Diffuse large B cell lymphoma, Central nervous system prophylaxis, Extranodal lymphoma, MYD88, Cell of origin, Radiation therapy
Journal
CURRENT TREATMENT OPTIONS IN ONCOLOGY
Volume 19, Issue 8, Pages -
Publisher
Springer Nature
Online
2018-06-21
DOI
10.1007/s11864-018-0555-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High prevalence ofMYD88andCD79Bmutations in intravascular large B-cell lymphoma
- (2018) Anne M. R. Schrader et al. BLOOD
- Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
- (2018) Roland Schmitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy
- (2017) Tarec Christoffer El-Galaly et al. EUROPEAN JOURNAL OF CANCER
- Prognostic impact of CD5 expression in diffuse large B-cell lymphoma in patients treated with rituximab-EPOCH
- (2017) Beenu Thakral et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- EZH2 overexpression in primary gastrointestinal diffuse large B-cell lymphoma and its association with the clinicopathological features
- (2017) Yang Liu et al. HUMAN PATHOLOGY
- Clinical Impact of the Cell-of-Origin Classification and the MYC/BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group
- (2017) Annette M. Staiger et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular analysis of immunoglobulin variable genes supports a germinal center experienced normal counterpart in primary cutaneous diffuse large B-cell lymphoma, leg-type
- (2017) Anne Pham-Ledard et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Primary Breast Lymphoma in the United States: 1975–2013
- (2017) Alexandra Thomas et al. JNCI-Journal of the National Cancer Institute
- Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets
- (2017) K Karube et al. LEUKEMIA
- Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCL
- (2017) Mareike Frick et al. LEUKEMIA & LYMPHOMA
- Primary Breast Lymphoma in the United States: 1975–2013
- (2017) Alexandra Thomas et al. JNCI-Journal of the National Cancer Institute
- Cutaneous B-cell lymphomas: 2016 update on diagnosis, risk-stratification, and management
- (2016) Ryan A. Wilcox AMERICAN JOURNAL OF HEMATOLOGY
- De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort
- (2016) Lapo Alinari et al. AMERICAN JOURNAL OF HEMATOLOGY
- Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell Lymphoma
- (2016) Kohei Taniguchi et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL
- (2016) K. J. Savage et al. BLOOD
- Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era
- (2016) Robert Kridel et al. BRITISH JOURNAL OF HAEMATOLOGY
- Uterine, but not ovarian, female reproductive organ involvement at presentation by diffuse large B-cell lymphoma is associated with poor outcomes and a high frequency of secondary CNS involvement
- (2016) Tarec Christoffer El-Galaly et al. BRITISH JOURNAL OF HAEMATOLOGY
- Site of central nervous system (CNS) relapse in patients with diffuse large B-cell lymphoma (DLBCL) by the CNS-IPI risk model
- (2016) Roopesh Kansara et al. BRITISH JOURNAL OF HAEMATOLOGY
- Central nervous system prophylaxis in diffuse large B-cell lymphoma
- (2016) Mohammad Faizan Zahid et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Lymphoma of the liver: Clinicopathological features of 19 patients
- (2016) Yue Peng et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO)
- (2016) Francisco-Javier Peñalver et al. HAEMATOLOGICA
- CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP
- (2016) Norbert Schmitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Primary bone diffuse large B-cell lymphoma: a retrospective evaluation on 76 cases from French institutional and LYSA studies
- (2016) Sylvain Pilorge et al. LEUKEMIA & LYMPHOMA
- Analysis of clinical characteristics and outcome of patients with previously untreated diffuse large B-cell lymphoma and renal involvement in the rituximab era
- (2016) Nicola Lehners et al. LEUKEMIA & LYMPHOMA
- P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma
- (2016) Xuan J Wang et al. MODERN PATHOLOGY
- Clinicopathological features of 49 primary gastrointestinal diffuse large B-cell lymphoma cases; comparison with location, cell-of-origin, and frequency of MYD88 L265P
- (2016) Keina Nagakita et al. PATHOLOGY INTERNATIONAL
- Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era
- (2016) A Kawajiri et al. Blood Cancer Journal
- Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO)
- (2016) Francisco-Javier Peñalver et al. HAEMATOLOGICA
- Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma
- (2015) Tarec Christoffer El-Galaly et al. AMERICAN JOURNAL OF HEMATOLOGY
- Targetable genetic features of primary testicular and primary central nervous system lymphomas
- (2015) B. Chapuy et al. BLOOD
- Validation of clinical prognostic indices for diffuse large B-cell lymphoma in the National Cancer Data Base
- (2015) Adam J. Olszewski et al. CANCER CAUSES & CONTROL
- Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas
- (2015) E. Braggio et al. CLINICAL CANCER RESEARCH
- Update in primary pulmonary lymphomas
- (2015) Jose Cardenas-Garcia et al. CURRENT OPINION IN PULMONARY MEDICINE
- Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study
- (2015) Siria A. Lemma et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Benefit of Consolidative Radiation Therapy for Primary Bone Diffuse Large B-Cell Lymphoma
- (2015) Randa Tao et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Oncogenic Mutations and Chromosomal Aberrations in Primary Extranodal Diffuse Large B-Cell Lymphomas of the Thyroid—A Study of 21 Cases
- (2015) Juliana Knief et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium
- (2015) L Deng et al. LEUKEMIA
- Diffuse large B-cell lymphoma: sites of extranodal involvement are a stronger prognostic indicator than number of extranodal sites in the rituximab era
- (2015) Chieh-Sheng Lu et al. LEUKEMIA & LYMPHOMA
- High prevalence of theMYD88mutation in testicular lymphoma: Immunohistochemical and genetic analyses
- (2015) Naoki Oishi et al. PATHOLOGY INTERNATIONAL
- Patients with primary diffuse large B-cell lymphoma of female genital tract have high risk of central nervous system relapse
- (2014) Xin-xin Cao et al. ANNALS OF HEMATOLOGY
- The role of radiotherapy and intrathecal CNS prophylaxis in extralymphatic craniofacial aggressive B-cell lymphomas
- (2014) N. Murawski et al. BLOOD
- Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis
- (2014) A. M. Petrich et al. BLOOD
- Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study)
- (2014) Carlo Messina et al. BRITISH JOURNAL OF HAEMATOLOGY
- Prognostic significance of soft tissue extension, International Prognostic Index, and multifocality in primary bone lymphoma: a single institutional experience
- (2014) Huanwen Wu et al. BRITISH JOURNAL OF HAEMATOLOGY
- A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era
- (2014) Peter J. Hosein et al. BRITISH JOURNAL OF HAEMATOLOGY
- Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era
- (2014) Andrés J. M. Ferreri et al. BRITISH JOURNAL OF HAEMATOLOGY
- Double hit lymphoma: the MD Anderson Cancer Center clinical experience
- (2014) Yasuhiro Oki et al. BRITISH JOURNAL OF HAEMATOLOGY
- Risk of CNS dissemination in extranodal lymphomas
- (2014) Andrés J M Ferreri LANCET ONCOLOGY
- Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of Lymphoma
- (2014) Gyeong-Won Lee et al. LEUKEMIA & LYMPHOMA
- Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma
- (2014) Adam J. Olszewski et al. LEUKEMIA RESEARCH
- Clinical Features, Management, and Prognosis of an International Series of 161 Patients With Limited-Stage Diffuse Large B-Cell Lymphoma of the Bone (the IELSG-14 Study)
- (2014) M. Bruno Ventre et al. ONCOLOGIST
- Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity
- (2014) S-H Kuo et al. Blood Cancer Journal
- Improvement of Survival in Patients With Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, in France
- (2014) Florent Grange et al. JAMA Dermatology
- High Frequency and Clinical Prognostic Value of MYD88 L265P Mutation in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type
- (2014) Anne Pham-Ledard et al. JAMA Dermatology
- Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: An analysis of the Surveillance, Epidemiology and End Results database
- (2013) Jorge J. Castillo et al. AMERICAN JOURNAL OF HEMATOLOGY
- Primary adrenal lymphoma: a systematic review
- (2013) Armin Rashidi et al. ANNALS OF HEMATOLOGY
- MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
- (2013) H. Horn et al. BLOOD
- An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
- (2013) Z. Zhou et al. BLOOD
- Primary Thyroid Lymphoma: A Clinical Review
- (2013) Stephanie Aleskow Stein et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Impact of Rituximab and Radiotherapy on Outcome of Patients With Aggressive B-Cell Lymphoma and Skeletal Involvement
- (2013) Gerhard Held et al. JOURNAL OF CLINICAL ONCOLOGY
- Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles
- (2013) David Cunningham et al. LANCET
- High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma
- (2013) W Kraan et al. LEUKEMIA
- Impact of rituximab on incidence of and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis
- (2013) Jing Zhang et al. LEUKEMIA & LYMPHOMA
- Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma
- (2013) Anne Pham-Ledard et al. MODERN PATHOLOGY
- Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma
- (2013) Kieron Dunleavy et al. NEW ENGLAND JOURNAL OF MEDICINE
- The comparison between CHOP and R-CHOP in primary gastric diffuse large B cell lymphoma
- (2012) Byeong Seok Sohn et al. ANNALS OF HEMATOLOGY
- Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study
- (2012) L. de Leval et al. ANNALS OF ONCOLOGY
- Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study
- (2012) H. Holte et al. ANNALS OF ONCOLOGY
- Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas
- (2012) S.-H. Kuo et al. BLOOD
- Helicobacter pylori eradication as exclusive treatment for limited-stage gastric diffuse large B-cell lymphoma: results of a multicenter phase 2 trial
- (2012) A. J. M. Ferreri et al. BLOOD
- Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
- (2012) Z. Y. Xu-Monette et al. BLOOD
- Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas
- (2012) A. Gonzalez-Aguilar et al. CLINICAL CANCER RESEARCH
- Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
- (2012) Tina Marie Green et al. JOURNAL OF CLINICAL ONCOLOGY
- Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
- (2012) Nathalie A. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)
- (2012) Yu Kim et al. Journal of Hematology & Oncology
- The Role of Genotype in 104 Cases of Diffuse Large B-Cell Lymphoma Primary of Breast
- (2011) Agustin Aviles et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab
- (2011) K. Miyazaki et al. ANNALS OF ONCOLOGY
- The molecular pathogenesis of primary mediastinal large B-cell lymphoma
- (2011) C. Steidl et al. BLOOD
- Clinicopathological features of 171 cases of primary thyroid lymphoma: a long-term study involving 24 553 patients with Hashimoto’s disease
- (2011) Natsuko Watanabe et al. BRITISH JOURNAL OF HAEMATOLOGY
- Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era
- (2011) Hiroyuki Takahashi et al. CANCER
- Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era
- (2011) Anita Kumar et al. CANCER
- Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse
- (2011) D. Villa et al. HAEMATOLOGICA
- Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy
- (2011) Ho-Young Yhim et al. INTERNATIONAL JOURNAL OF CANCER
- First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial
- (2011) Umberto Vitolo et al. JOURNAL OF CLINICAL ONCOLOGY
- Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial
- (2011) Christian Récher et al. LANCET
- Treatment results and prognostic factors in primary thyroid lymphoma patients: a Rare Cancer Network study
- (2010) C. Onal et al. ANNALS OF ONCOLOGY
- Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma
- (2010) Jeremy S. Abramson et al. CANCER
- CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
- (2009) V. Boehme et al. BLOOD
- MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy
- (2009) K. J. Savage et al. BLOOD
- CXCL13 and CXCL12 in Central Nervous System Lymphoma Patients
- (2009) L. Fischer et al. CLINICAL CANCER RESEARCH
- Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations
- (2009) N. Tomita et al. HAEMATOLOGICA
- Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations
- (2009) N Niitsu et al. LEUKEMIA
- Natural History of CNS Relapse in Patients With Aggressive Non-Hodgkin's Lymphoma: A 20-Year Follow-Up Analysis of SWOG 8516—The Southwest Oncology Group
- (2008) Steven H. Bernstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
- (2008) Michael Pfreundschuh et al. LANCET ONCOLOGY
- Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group
- (2007) G. Ryan et al. ANNALS OF ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now